/Companies

Cyclops

9 known investors

Find your way into Cyclops

Sign up to see every warm intro you have to Cyclops

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Cyclops team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Cyclops Medtech develops a portfolio of vestibular diagnostic and therapy products—including videonystagmography (VNG/VOG), video head impulse testing (vHIT), dynamic visual acuity, stabilometry platforms, VR-based vestibular rehabilitation, and a smart balance board—to diagnose and treat dizziness and balance disorders. Its tools serve clinicians across neurotology, neurology, physiotherapy, audiology, and ophthalmology.

Investors · 9

Also in the syndicate · 3

Global PayTech VenturesLasagna VenturesShift4 Payments

Funding

SEC filings, press & company announcements

$20M disclosed across 1 of 2 rounds · 2026

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Cyclops do?
Cyclops Medtech develops a portfolio of vestibular diagnostic and therapy products—including videonystagmography (VNG/VOG), video head impulse testing (vHIT), dynamic visual acuity, stabilometry platforms, VR-based vestibular rehabilitation, and a smart balance board—to diagnose and treat dizziness and balance disorders. Its tools serve clinicians across neurotology, neurology, physiotherapy, audiology, and ophthalmology.
Who are Cyclops's investors?
Cyclops's investors include Capria Ventures, Castle Island Ventures, Circle & Co., Coinbase Ventures, F-Prime Capital, Nava Ventures.
How much funding has Cyclops raised?
Cyclops has disclosed $20M raised across 1 of its 2 known rounds.